UnitedHealth Group's Optum said the Justice Department's lawsuit to stop its acquisition of Amedisys is an overreach.

An aging U.S. population is increasing demand for home health care. The Optum-Amedisys merger, with divestitures to ...

Truist Financial analyst David S Macdonald maintained a Hold rating on Amedisys (AMED – Research Report) today and set a price target of ...

The government is citing concerns the deal would hinder access to home health and hospice services in the U.S.

UnitedHealth announced its plan to buy Amedisys, a major home health care provider, more than a year ago. Home health is a ...

Adds UnitedHealth comment.Amedisys (NASDAQ:AMED) dropped 1.8% as the Dept. of Justice confirmed it filed a lawsuit to ...

The Department of Justice is seeking to intervene in UnitedHealth Group's $3.3 billion acquisition of home health company ...

UnitedHealth's planned acquisition of home health and hospice company Amedisys has stalled once again, this time due to the U ...

Minnesota-based UnitedHealth Group Inc. is the focus of an antitrust lawsuit filed on Tuesday by the United States Department ...

Antitrust enforcers argue that the healthcare giant’s latest deal would illegally harm competition.

The U.S. Department of Justice and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion ...